The paper's citation list

No.
The paper's citation list
1
MASLD: predictive value for liver-related events and extra-hepatic complications. 2024;18:685 doi: 10.1080/17474124.2024.2435504
2
Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes. 2025;15: doi: 10.1038/s41598-025-01003-4
3
Cardiovascular Mortality in MASLD: A Matter of Fat. Caution in Interpreting Liver Fat Quantification in Populations With High Fibrosis Variability. 2025;6: doi: 10.1002/lci2.70014
4
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease. 2024;4: doi: 10.20517/mtod.2024.42
5
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification. 2025;42:1729 doi: 10.1007/s12325-025-03121-x
6
Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease-related compensated advanced chronic liver disease. 2025;31: doi: 10.3748/wjg.v31.i3.100393
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/